Evommune, Inc. Stock Performance
as on September 26, 2026 at 2:15 pm IST
Day's Low
Day's High
$8.33$8.62
1.88%
Downside
1.53%
Upside
52 Week's Low
52 Week's High
100.00%
Downside
-100.00%
Upside
Evommune, Inc. share price movements today
- Previous Close
- $8.80
- Open
- $8.61
- Volume
- 526.5K
- Market Cap
- $319.4M
- Day's Low - High
- $8.33 - $8.62
Evommune, Inc. Historical Returns
- 1 Month Return
- -39.83 %
- 3 Month Return
- -66.28 %
- 1 Year Return
- 0 %
- 3 Year Return
- 0 %
- 5 Year Return
- 0 %
Evommune, Inc. Stock Fundamentals & Key Indicators
Check Evommune, Inc. market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.
Market Cap
$319.4M
EPS (TTM)
-2.83
Dividend Yield
0.00%
PE Ratio (TTM)
-3.11
Industry PE ratio
-8.07
PEG Ratio
0.06044821954634374
Return On Equity TTM
-62.63%
Evommune, Inc. Stock Valuation
Track how Evommune, Inc. P/E has moved over time to understand its valuation trends.
Evommune, Inc. in the last 3 years
Lowest (-17.87x)
December 31, 2023
Industry (-8.07x)
December 31, 2025
Today (-7.85x)
December 31, 2025
Highest (-7.85x)
December 31, 2025
Today’s Price to Earnings Ratio: -7.85x
Evommune, Inc. vs Peer Comparison
Compare market cap, revenue, PE, and other key metrics of Evommune, Inc. with its industry peers.
Company | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin % | Dividend Yield % |
|---|---|---|---|---|---|---|
| StrongBuy | $319.4M | NA | -3.11 | 96.51% | 0.00% | |
| Neutral | $77.8B | -53.76% | -24.41 | -12.57% | 0.00% | |
| StrongBuy | $132.4B | 186.58% | 30.16 | 86.04% | 0.00% | |
| Buy | $82.8B | 23.34% | 19.01 | 84.86% | 0.46% |
Analyst Recommendation on Evommune, Inc. Stock
Based on 9 analysts
88.89%
Buy
11.11%
Hold
0.00%
Sell
Based on 9 analysts, 88.88888888888889% of analysts recommend a 'BUY' rating for Evommune, Inc.. Average target price of $23.4285714285714
Indian Investors' Interest in Evommune, Inc. Stock
Search interest for Evommune, Inc. Stock has increased by 158% in the last 30 days, reflecting an upward trend in search activity.
Time period: to
Change:158% versus previous 30 day period
Evommune, Inc. Quarterly Profit & Loss
All numbers in Millions USD
Evommune, Inc. Annual Profit & Loss
All numbers in Millions USD
Evommune, Inc. Quarterly Cash Flow
All numbers in Millions USD
Evommune, Inc. Annual Cash Flow
All numbers in Millions USD
Evommune, Inc. News & Key Events
Today's Timeline - 09 September
Wed, 04:03 PM
-Evommune shifts focus to EVO301 after EVO756 fails in atopic dermatitis trial.
Wed, 06:08 PM
-RBC Capital lowers Evommune price target to $21 from $29, citing disappointing EVO756 AD trial results.
Wed, 06:10 PM
-Leerink reduces Evommune price target to $22 from $28, following negative EVO756 trial results.
Today's Timeline - 09 September
Wed, 06:25 PM
-Raymond James cuts Evommune price target to $18 from $32, citing EVO756 AD failure.
Thu, 05:20 AM
-Clear Street lowers Evommune price target to $23 from $28, maintains Buy rating after EVO756 trial failure.
Insights on Evommune, Inc.
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
NEGATIVE IMPACTPrice Dip
In the last 7 days, EVMN stock has moved down by -12.0%
About Evommune, Inc.
| Organisation | Evommune, Inc. |
| Headquarters | 1841 Page Mill Road, Palo Alto, CA, 94304, US |
| Industry | Biotechnology |
| CEO | Luis C. Pena |
| E-voting on shares | Click here to vote |
Key Management of Evommune, Inc.
Name | Title |
|---|---|
Mr. Luis C. Pena | Founder, President, CEO & Director |
Dr. Eugene Andrew Bauer M.D. | Co-Founder, Chief Medical Officer & Director |
Dr. Jeegar Patel Ph.D. | Chief Scientific Officer |
Dr. Lou Sehl Ph.D. | Senior Vice President of Technical Operations |
Mr. Kyle Carver CPA, M.B.A. | Chief Financial Officer |
Mr. Gregory S. Moss Esq. | Chief Business & Legal Officer, Corporate Secretary and Chief Compliance Officer |
Ms. Janice Drew M.P.H. | Chief of Development Operations |
Dr. Daniel J. Burge M.d. | Senior Vice President of Clinical Development |
Mr. J. Mark Jackson M.D. | Senior Vice President of Clinical Development |
FAQs
What is Evommune, Inc. share price today?
Evommune, Inc. share price today is $8.49 as on at the close of the market. Evommune, Inc. share today touched a day high of $8.62 and a low of $8.33.
What is the 52 week high and 52 week low for Evommune, Inc. share?
Evommune, Inc. share touched a 52 week high of $0.00 on and a 52 week low of $0.00 on . Evommune, Inc. stock price today i.e. is closed at $8.49,which is -Infinity% down from its 52 week high and Infinity% up from its 52 week low.
What is Evommune, Inc.'s market capitalisation today?
Evommune, Inc. market capitalisation is $0.00T as on .
How to invest in Evommune, Inc. Stock (EVMN) from India?
- Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
- Step 2: Search for Evommune, Inc. on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Evommune, Inc. Shares that will get you 0.1767 shares as per Evommune, Inc. share price of $8.49 per share as on September 26, 2026 at 8:45 am IST.
What is the minimum amount required to buy Evommune, Inc. Stock (EVMN) from India?
Indian investors can start investing in Evommune, Inc. (EVMN) shares with as little as ₹95.819999694824 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹958.20 in Evommune, Inc. stock (as per the Rupee-Dollar exchange rate as on ).
Based on Evommune, Inc. share’s latest price of $8.49 as on September 26, 2026 at 8:45 am IST, you will get 1.1779 shares of Evommune, Inc.. Learn more about
fractional shares .